Large Molecule Bioanalytical Testing Service Market

Global Large Molecule Bioanalytical Testing Service Market by Phases (Preclinical, With Antibody, Without Antibody (ELISA Based Assay), and Clinical), Types (Pharmacokinetics, ADA, and Others), Test Types (ADME, PK, PD, Bioavailability, Bioequivalence, and Other Tests), Therapeutic Areas (Oncology, Infectious Diseases, Cardiology, Neurology, and Others), End-users (SMEs [CROs & CMOs, Sponsor Organizations, and Others] and Large Firms [CROs & CMOs, Sponsor Organizations, and Others]), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2020-2027

  • Report ID: HC-140
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 0
  • No. Of Pages: 120
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global large molecule bioanalytical testing service market is anticipated to expand at substantial CAGR during forecast period, between 2020 and 2027. Large molecule bioanalysis operates in the field of analytical chemistry. These large drug molecules are effective in treating a range of indications of chronic illness. The growth of the biopharmaceutical R&D pipeline has boosted the demand for large molecules bioanalytical testing services; therefore, many biopharmaceutical companies are introducing large-scale outsourcing services. Bioanalytical research of big molecules has always been a challenge for the biopharmaceutical industry. Various specialized methods are HRMS, scale exclusion affinity chromatography, ligand binding assays (LBA) and Maldi-TOF-MS. Bioanalytical studies for large molecules can easily be conducted using these advanced techniques.

Market Trends, Drivers, Restraints, and Opportunities:

  • Technological advancements in bioanalytical research for the large molecule fuels market growth.
  • Increase in emphasis on analytical testing, rise in research & development costs in the pharmaceutical and biopharmaceutical industries, and growth in the demand for analytical test outsourcing fuel market growth.
  • Compliance issues while outsourcing large molecule bioanalytical testing services are expected to hamper the market.

Scope of the report:

The report on large molecule bioanalytical testing service market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
 

Attributes

Details

Base Year

2019

Historic Data

2017 & 2018

Forecast Period

2020–2027

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast
















 

Large Molecule Bioanalytical Testing Service Market Segment Insights:

The clinical segment is projected to hold significant market share

In the terms of phases, the large molecule bioanalytical testing service market has been segmented into preclinical, with antibody, without antibody (ELISA-based assay), and clinical. The clinical segment is projected to grow at a significant pace during the forecast period due to the growing prevalence of chronic diseases in developing countries and rising need for clinical trials.

Antidrug antibodies (ADA) segment held substantial market share in 2019

Based on types, the market is fragmented into pharmacokinetics, ADA, and others. The antidrug antibodies (ADA) segment holds significant market share is projected to expand at rapid rate during the forecast period. ADA assays promote large molecular drug production.

Bioavailability segment is expected to grow during the forecast period

On the basis of test types, the large molecule bioanalytical testing service market has been segregated into ADME, PK, PD, bioavailability, bioequivalence, and other tests. The bioavailability segment is expected to hold significant market share during the forecast period. The bioavailability of a pharmaceutical medicine partly depends on the characteristics of a dosage form. It plays a key role in pharmacokinetics, as it is taken non-intravenous dose calculations.

Surge in prevalence of cancer fuels the oncology segment

In terms of therapeutic areas, the market is classified as oncology, infectious diseases, cardiology, neurology, and others. The oncology segment holds a significant share of the market due to high prevalence of cancer across the globe. The cardiology segment is projected to expand at substantial CAGR during the forecast period.

Small and Medium Enterprises (SMEs) segment holds significant market share

Based on end-users, the large molecule bioanalytical testing service market is bifurcated into SME and large firm. Both segments are further divided into CROs & CMOs, sponsor organizations, and others. The development of biopharmaceutical inventions in the US, for example, due to increase in the demand for SMEs for products, processes, and services.

North America dominates the global market

In terms of regions, the global large molecule bioanalytical testing service market is split into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounts for a considerable share of the large molecule bioanalytical testing service market. The US has numerous manufacturing facilities for extremely effective, complex, and high-end medications. The market is expected to develop significantly in the US during the forecast period due to the rapid increase in biologic production to meet the growing demand for efficient medical care in the country, strong R&D, and promotion of new therapies.

Competitive Landscape:

Key players in the large molecule bioanalytical testing service market include Charles River Laboratory International, Covance, Inc., ICON Plc, Intertek Group plc, IQVIA, Pace Analytical Services LLC, PPD, INC., SGS SA, Syneos Health, and Toxikon. Mergers & acquisitions, collaborations, agreements, and partnerships are some growth strategies adopted by these players to strengthen their geographical presence.

Segments Covered in the Report

By Phases

  • Preclinical
  • With Antibody
  • Without Antibody (ELISA Based Assay)
  • Clinical

By Types

  • Pharmacokinetics
  • ADA
  • Others

By Test Types

  • ADME
  • PK
  • PD
  • Bioavailability
  • Bioequivalence
  • Other Tests

By Therapeutic Areas

  • Oncology
  • Infectious Diseases
  • Cardiology
  • Neurology
  • Others

By End-users

  • SMEs
    • CROs & CMOs
    • Sponsor Organizations
    • Others (Academic institute, etc.)
  • Large Firms
    • CROs & CMOs
    • Sponsor Organizations
    • Others (Academic institute, etc.)

By Regions

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Large Molecule Bioanalytical Testing Service Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Large Molecule Bioanalytical Testing Service Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Large Molecule Bioanalytical Testing Service Market - Supply Chain
  4.5. Global Large Molecule Bioanalytical Testing Service Market Forecast
     4.5.1. Large Molecule Bioanalytical Testing Service Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Large Molecule Bioanalytical Testing Service Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Large Molecule Bioanalytical Testing Service Market Absolute $ Opportunity
5. Global Large Molecule Bioanalytical Testing Service Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Types
     5.3.1. Pharmacokinetics
     5.3.2. ADA
     5.3.3. Others
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Large Molecule Bioanalytical Testing Service Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by End Users
     6.3.1. SMEs
     6.3.2. CROs & CMOs
     6.3.3. Sponsor Organizations
     6.3.4. Others (Academic institute, etc.)
     6.3.5. Large Firms
     6.3.6. CROs & CMOs
     6.3.7. Sponsor Organizations
     6.3.8. Others (Academic institute, etc.)
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Large Molecule Bioanalytical Testing Service Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Large Molecule Bioanalytical Testing Service Demand Share Forecast, 2019-2026
8. North America Large Molecule Bioanalytical Testing Service Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Types
     8.4.1. Pharmacokinetics
     8.4.2. ADA
     8.4.3. Others
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by End Users
     8.7.1. SMEs
     8.7.2. CROs & CMOs
     8.7.3. Sponsor Organizations
     8.7.4. Others (Academic institute, etc.)
     8.7.5. Large Firms
     8.7.6. CROs & CMOs
     8.7.7. Sponsor Organizations
     8.7.8. Others (Academic institute, etc.)
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Large Molecule Bioanalytical Testing Service Demand Share Forecast, 2019-2026
9. Latin America Large Molecule Bioanalytical Testing Service Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Types
     9.4.1. Pharmacokinetics
     9.4.2. ADA
     9.4.3. Others
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by End Users
     9.7.1. SMEs
     9.7.2. CROs & CMOs
     9.7.3. Sponsor Organizations
     9.7.4. Others (Academic institute, etc.)
     9.7.5. Large Firms
     9.7.6. CROs & CMOs
     9.7.7. Sponsor Organizations
     9.7.8. Others (Academic institute, etc.)
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Large Molecule Bioanalytical Testing Service Demand Share Forecast, 2019-2026
10. Europe Large Molecule Bioanalytical Testing Service Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Types
     10.4.1. Pharmacokinetics
     10.4.2. ADA
     10.4.3. Others
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by End Users
     10.7.1. SMEs
     10.7.2. CROs & CMOs
     10.7.3. Sponsor Organizations
     10.7.4. Others (Academic institute, etc.)
     10.7.5. Large Firms
     10.7.6. CROs & CMOs
     10.7.7. Sponsor Organizations
     10.7.8. Others (Academic institute, etc.)
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Large Molecule Bioanalytical Testing Service Demand Share Forecast, 2019-2026
11. Asia Pacific Large Molecule Bioanalytical Testing Service Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Types
     11.4.1. Pharmacokinetics
     11.4.2. ADA
     11.4.3. Others
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by End Users
     11.7.1. SMEs
     11.7.2. CROs & CMOs
     11.7.3. Sponsor Organizations
     11.7.4. Others (Academic institute, etc.)
     11.7.5. Large Firms
     11.7.6. CROs & CMOs
     11.7.7. Sponsor Organizations
     11.7.8. Others (Academic institute, etc.)
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Large Molecule Bioanalytical Testing Service Demand Share Forecast, 2019-2026
12. Middle East & Africa Large Molecule Bioanalytical Testing Service Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by Types
     12.4.1. Pharmacokinetics
     12.4.2. ADA
     12.4.3. Others
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Large Molecule Bioanalytical Testing Service Market Size and Volume Forecast by End Users
     12.7.1. SMEs
     12.7.2. CROs & CMOs
     12.7.3. Sponsor Organizations
     12.7.4. Others (Academic institute, etc.)
     12.7.5. Large Firms
     12.7.6. CROs & CMOs
     12.7.7. Sponsor Organizations
     12.7.8. Others (Academic institute, etc.)
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Large Molecule Bioanalytical Testing Service Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Large Molecule Bioanalytical Testing Service Market: Market Share Analysis
  13.2. Large Molecule Bioanalytical Testing Service Distributors and Customers
  13.3. Large Molecule Bioanalytical Testing Service Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Charles River Laboratory International
     13.4.2. Covance Inc.
     13.4.3. ICON Plc
     13.4.4. Intertek Group plc
     13.4.5. IQVIA
     13.4.6. Pace Analytical Services LLC
     13.4.7. PPD INC.
     13.4.8. SGS SA
     13.4.9. Syneos Health
     13.4.10. Toxikon

Segments Covered in the Report
By Phases

  • Preclinical
  • With Antibody
  • Without Antibody (ELISA Based Assay)
  • Clinical

By Types
  • Pharmacokinetics
  • ADA
  • Others

By Test Types
  • ADME
  • PK
  • PD
  • Bioavailability
  • Bioequivalence
  • Other Tests

By Therapeutic Areas
  • Oncology
  • Infectious Diseases
  • Cardiology
  • Neurology
  • Others

By End-users
  • SMEs
    • CROs & CMOs
    • Sponsor Organizations
    • Others (Academic institute, etc.)
  • Large Firms
    • CROs & CMOs
    • Sponsor Organizations
    • Others (Academic institute, etc.)

By Regions
  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa


Key Players in the market

  • Charles River Laboratory International
  • Covance Inc.
  • ICON Plc
  • Intertek Group plc
  • IQVIA
  • Pace Analytical Services LLC
  • PPD INC.
  • SGS SA
  • Syneos Health
  • Toxikon

Buy Report